G9766 HCPCS Level II code: Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment
G9766 is the HCPCS code for “Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G9766Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment
Short description: Cva stroke dx tx transf fac
HCPCS · United States
Medicare details
The indicators CMS publishes with G9766 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2017
Where G9766 sits
- 1G codesProcedures and professional services
- 2Active code G9766Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G9766 mean?
G9766 is the HCPCS code for “Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G9766?
CMS lists G9766’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9766
All G codesG9760Patients who use hospice services any time during the measurement periodG9761Patients who use hospice services any time during the measurement periodG9762Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdaysG9763Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdaysG9764Patient has been treated with a systemic medication for psoriasis vulgarisG9765Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic…G9767Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatmentG9768Patients who utilize hospice services any time during the measurement periodG9769Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 monthsG9770Peripheral nerve block (pnb)G9771At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes…G9772Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the…